Optimized AAV vectors for therapeutic Schwann cell targeting in NF1
syn36530073
Created By
review-service
dataType: raw counts
studyName: Optimized AAV vectors for therapeutic Schwann cell targeting in NF1
dataStatus: Under Embargo
initiative: Gene Therapy Initiative
studyLeads: J. Elliott Robinson
studyStatus: Active
diseaseFocus: Neurofibromatosis type 1
grantEndDate: 1735603200000
institutions: Cincinnati Children's Hospital Medical Center
fundingAgency: GFF
embargoEndDate: 1767139200000
grantStartDate: 1640995200000
relatedStudies: syn36544421 syn36362557 syn36544414 syn36363358
studyFileviewId: syn36530084
syn36530078
syn51077492
syn53335704
syn36530079
syn36530084
syn36530081
syn51077506
Drop files to upload
Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this
AJAX application crawl link
Optimized AAV vectors for therapeutic Schwann cell targeting in NF1
page is loading…